Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers


Malkan Ü. Y. , Gunes G., Corakci A.

SPRINGERPLUS, vol.4, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 4
  • Publication Date: 2015
  • Doi Number: 10.1186/s40064-015-1389-5
  • Journal Name: SPRINGERPLUS
  • Journal Indexes: Science Citation Index Expanded
  • Keywords: 1,5-Anhydroglucitol, Glycated hemoglobin, Fructosamine, Prediabetes, Diabetes mellitus, Diagnosis, ORAL GLUCOSE-TOLERANCE, PLASMA-GLUCOSE, MELLITUS, A1C, FRUCTOSAMINE, ASSOCIATION, HEMOGLOBIN, INDEX, TESTS, WELL

Abstract

Diabetes mellitus (DM) is a frequently encountered disease with important morbidity and mortality. The aim of this study is to document the importance of 1,5-anhydroglucitol (1,5-AG) for the diagnosis of prediabetes and DM, as well as to compare the 1,5-AG with other glycemic markers in order to understand which one is the better diagnostic tool. Between April 2012 and December 2012, 128 participants enrolled in the study. Participants were split into five groups that are IFG, IGT, IFG+IGT, diabetic and control groups by their OGTT results. The diagnostic value of markers was compared by ROC (receiver operating characteristic) method. The mean serum 1,5-AG levels in the diabetic group (33.38 nmol/ml) were lower than, IFG (59.83 nmol/ml), IGT (54.44 nmol/ml), IFG+IGT (51.98 nmol/ml) and control groups (73.24 nmol/ml). When analyzed in the total study population serum 1,5-AG levels did not differ by gender significantly. When analyzed in the total study population, 1,5-AG correlates inversely with age significantly (p = 0.036). In subgroup analysis, in the control group, serum 1,5-AG level was also inversely correlated with age (p = 0.087). The best marker for the diagnosis of prediabetes and DM was fasting plasma glucose (FPG). 1,5-AG was not found to be effective for the diagnosis of DM. This study, contributes to our knowledge of the efficiency and cut-off values of 1,5-AG for the diagnosis of prediabetes and DM. In future, there is a need for larger studies with more standardized and commonly used measurement methods for 1,5-AG, in order to evaluate the efficiency of 1,5-AG for the diagnosis of prediabetes and DM.